Abstract:Introduction: Dynamin-related protein 1 (Drp1) activation increases mitochondrial fission and cell cycle progression in hyperproliferative cells, termed mitotic fission. However, the diameter of a fission apparatus comprised solely of Drp1 and its binding partners appears insufficient to complete fission. Moreover, the mechanism linking fission to cell cycle progression is unknown, suggesting an additional mediator in the terminal steps of mitotic fission. Hypothesis: The large GTPase, dynamin 2 (DNM2), interacts with Drp1 to complete mitochondrial fission and regulate cell cycle progression. Corollary: DNM2 is epigenetically upregulated in pulmonary arterial smooth muscle cells in pulmonary arterial hypertension (PAH PASMC). Methods: Mitochondrial morphology, protein colocalization and mitochondrial fission sites were assessed using super-resolution microscopy. Protein-protein interaction was confirmed using immunoprecipitation. The role of the DNM2 GTPase domain in mitochondrial targeting was studied by heterologous expression of truncated constructs. Transcriptomic changes from silencing DNM2 in PAH PASMC were measured by RNA-seq. DNM2 expression was quantified in normal and PAH PASMC and lungs from PAH patients and rats with monocrotaline (MCT) and SU5416/hypoxia (Su/Hx)-induced PAH. The effects of manipulating DNM2 on cell proliferation, cell cycle progression and apoptosis were assessed by flow cytometry. siRNA targeting DNM2 was nebulized to rats with MCT-PAH. Results: DNM2 is increased in PAH PASMC in humans and rodents and interacts with Drp1 via its GTPase domain, permitting mitochondrial translocation. Silencing DNM2 in PAH PASMC inhibits fission and slows cell proliferation by causing G1/G0 phase blockade. Augmenting DNM2 in normal PASMC induces fission and accelerates proliferation. siDNM2 downregulates the positive cell cycle regulator, Regulator of Cell Cycle (RGCC), in PAH PASMC. Moreover, siRGCC causes G1/G0 cell cycle arrest. miR-124-3p negatively regulates DNM2 and is decreased in PAH PASMC. Augmenting miR-124-3p in PAH PASMC decreases DNM2, inhibits proliferation and induces apoptosis. STAT3 is also negatively regulated by miR-124-3p and siSTAT3 reduces DNM2 and mitochondrial fission in PAH PASMC. Nebulized siDNM2 regresses PAH in MCT-PAH. Conclusion: DNM2 GTPase domain binds Drp1, mediating mitochondrial translocation and tighter mitochondrial fission. DNM2 is upregulated in PAH by miR-124a-3p deficiency and STAT3 activation. The miR-124a-3p-STAT3-DNM2-Drp1-RGCC pathway underlies accelerated mitotic fission in PAH and offers novel therapeutic targets.

LncND5 encoded by mitochondrial genomes regulating mitochondrial autophagy via activation of complex Ⅰ and binding to HMGCS1

Leber's Hereditary Optic Neuropathy (Lhon)-Associated ND5 12338T > C Mutation Altered the Assembly and Function of Complex I, Apoptosis and Mitophagy.

LINC00599 Promotes Pulmonary Hypertension via LLPS with G3BP1 and MYH9

Super Enhancer-driven LncRNA UNC5B-AS1 Inhibits Inflammatory Phenotypic Transition in Smooth Muscle Cells via Lactylation Modification

#4478 HIF-1α REGULATED LNCRNA-ATP6V0E2-AS1 MEDIATES HYPOXIA-INDUCED MITOPHAGY IN RENAL TUBULAR CELLS

Mitochondrial sequencing identifies long noncoding RNA features that promote binding to PNPase

Advances in studying the role of long noncoding RNA in pulmonary hypertension

A Regulatory Signaling Loop Comprising the PGAM5 Phosphatase and CK2 Controls Receptor-Mediated Mitophagy

Role of Dynamin 2 in mitochondrial fission and cell cycle regulation: Dysregulation of a miR-124-3p-STAT3-DNM2-Drp1-RGCC pathway connects fission and cell proliferation in pulmonary arterial hypertension

The BCL2L1 and PGAM5 axis defines hypoxia-induced receptor-mediated mitophagy

Phospholipase A2-activating protein induces mitophagy through anti-apoptotic MCL1-mediated NLRX1 oligomerization

Role of mitophagy in pulmonary hypertension: Targeting the mechanism and pharmacological intervention

Allele-specific control of rodent and human lncRNA KMT2E-AS1 promotes hypoxic endothelial pathology in pulmonary hypertension

Mitochondrial long non-coding RNA GAS5 tunes TCA metabolism in response to nutrient stress

Linking lncRNAs to regulation, pathogenesis, and diagnosis of pulmonary hypertension

LncRNA PVT1 Mediated by ZFP36L2 Regulates Myocardial Ischemia/Reperfusion Injury and Attenuates Mitochondrial Fusion and Fission via Activating miR-21-5p/MARCH5 Axis

The lncRNA Punisher Regulates Apoptosis and Mitochondrial Homeostasis of Vascular Smooth Muscle Cells via Targeting miR-664a-5p and OPA1

lncRNA Gm20257 alleviates pathological cardiac hypertrophy by modulating the PGC-1α-mitochondrial complex IV axis

Overexpressed lncRNA AC068039.4 contributes to proliferation and cell cycle progression of pulmonary artery smooth muscle cells via sponging miR-26a-5p/TRPC6 in hypoxic pulmonary arterial hypertension

The effects of mitochondria-associated long noncoding RNAs in cancer mitochondria: New players in an old arena

The Nucleus/Mitochondria-Shuttling LncRNAs Function as New Epigenetic Regulators of Mitophagy in Cancer